Health
A COUPLE DECIDED TO BREAK OFF MEDICAL TREATMENT FOR NEW AGE TREATMENT
COUPLE JAIL FOR 3 YEARS BY GERMAN COURT
(Source: © Ruby BIRD & Yasmina BEDDOU)
(Source: © Ruby BIRD & Yasmina BEDDOU)
The son, now twenty-eight, told the Court that he became severely malnourished after his treatment was discontinued. At the age of fifteen, he managed to escape from his mother and step-father to get refuge to his biological father and get medical treatment. His weight has dropped dramatically and his lungs have been damaged beyond repair. His condition was life-threatening and would have led to death without further treatment.
Cystic Fibrosis is a life-threatenic, genetic disease that causes persistent lung infections and progressively limits the ability to breath. In people with Cystic Fibrosis, a defected gene causes a thick, buildup of mucus in the lungs, pancreas and other organs. In the lungs, the mucus clogs the airways and traps bacteria leading to infections, extensive lung damage and eventually, respiratory failure. In the pancreas, the mucus prevents the release of digestive enzymes that allow the body to break down food and absorb vital nutrients.
In the USA, about 30,000 people are living with Cystic Fibrosis (70,000 worldwide). Approximately 1,000 new cases are diagnosed each year.
In the USA, about 30,000 people are living with Cystic Fibrosis (70,000 worldwide). Approximately 1,000 new cases are diagnosed each year.
More than 75 % of people with Cystic Fibrosis are diagnosed by age two. nearly half of the Cystic Fibrosis population is age 18 older.
Regarding the treatments, the type and severity of Cystic Fibrosis symptoms can differ widely from person to person. Therefore, there is not a typical treatment plan.
In 2015, the FDA approved the second drug to treat the root cause of Cystic Fibrosis, a defective protein known as CFTR. The first drug targeting the basic genetic defect in Cystic Fibrosis was approved in 2012. It's expected that CFTR modulators could add decades of life for some people with Cystic Fibrosis. (Cystic Fibrosis Foundation)
Regarding the treatments, the type and severity of Cystic Fibrosis symptoms can differ widely from person to person. Therefore, there is not a typical treatment plan.
In 2015, the FDA approved the second drug to treat the root cause of Cystic Fibrosis, a defective protein known as CFTR. The first drug targeting the basic genetic defect in Cystic Fibrosis was approved in 2012. It's expected that CFTR modulators could add decades of life for some people with Cystic Fibrosis. (Cystic Fibrosis Foundation)
Ruby Bird Yasmina Beddou Berlin Jail Treatment Cystic Fibrosis New Age Medication Danger Judge Court Safety Torture Cult Leader Weight Loss
Liability for this article lies with the author, who also holds the copyright. Editorial content from USPA may be quoted on other websites as long as the quote comprises no more than 5% of the entire text, is marked as such and the source is named (via hyperlink).
